BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 413921)

  • 1. Semisynthetic aminoglycoside antibacterials. 6. Synthesis of sisomicin, Antibiotic G-52, and novel 6'-substituted analogues of sisomicin from aminoglycoside 66-40C.
    Davies DH; Mallams AK; Counelis M; Loebenberg D; Moss EL; Waitz JA
    J Med Chem; 1978 Feb; 21(2):189-93. PubMed ID: 413921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of sisomicin, an aminoglycoside antibiotic, against clinical isolates.
    Stewart D; Bodey GP
    J Antibiot (Tokyo); 1975 Feb; 28(2):149-55. PubMed ID: 234415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of the effect of sisomicin and other aminoglycosides on the causative agents of surgical infection].
    Navashin PS
    Antibiotiki; 1982 Dec; 27(12):26-9. PubMed ID: 6819812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial activity of sisomicin.
    Rossi A; Branca G; Manzara S; Morace G; Polonelli L; Spagnolo N; Ttonci M
    J Int Med Res; 1978; 6(2):94-101. PubMed ID: 415913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of 5-episisomicin compared with that of other aminoglycosides.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1978 Aug; 14(2):194-200. PubMed ID: 697347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.
    Miller GH; Arcieri G; Weinstein MJ; Waitz JA
    Antimicrob Agents Chemother; 1976 Nov; 10(5):827-36. PubMed ID: 1008541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of netilmicin against selected strains of Gram-negative bacteria and Staphylococcus aureus: comparison with four other aminoglycosides.
    Mouton RP; de Kok-Broeren MC
    J Antimicrob Chemother; 1977 Sep; 3(5):393-401. PubMed ID: 903322
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial activity of sisomicin in comparison with gentamicin].
    Scheer M
    Arzneimittelforschung; 1976; 26(5):772-8. PubMed ID: 9099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sisomicin versus netilmicin: in vitro susceptibility testing.
    Flournoy DJ
    Antimicrob Agents Chemother; 1976 Nov; 10(5):864-5. PubMed ID: 827238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of netilmicin, a new aminoglycoside antibiotic, compared with that of gentamicin.
    Phillips I; Smith A; Shannon K
    Antimicrob Agents Chemother; 1977 Mar; 11(3):402-6. PubMed ID: 301004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies with sisomicin and gentamicin.
    Shadomy S; Utz CJ; Shadomy HJ
    Chemotherapy; 1976; 22(6):346-52. PubMed ID: 821725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structure of aminoglycoside antibiotic 66-40G produced by Micromonospora inyoensis.
    Kugelman M; Jaret RS; Mittelman S; Gau W
    J Antibiot (Tokyo); 1978 Jul; 31(7):643-5. PubMed ID: 689999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination effect with some aminoglycoside antibiotics.
    Jedlicková Z; Rýc M; Libánská A
    J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):204-6. PubMed ID: 6788839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of 5-episisomicin in bacteria resistant to other aminoglycoside antibiotics.
    Kabins SA; Nathan C
    Antimicrob Agents Chemother; 1978 Sep; 14(3):391-7. PubMed ID: 101131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin.
    Zhanel GG; Lawson CD; Zelenitsky S; Findlay B; Schweizer F; Adam H; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
    Expert Rev Anti Infect Ther; 2012 Apr; 10(4):459-73. PubMed ID: 22512755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical applications of sisomicin and netilmicin. Previous and current state of microbiological results].
    Altucci P; Abbate GF; Alagia I; D'Aprea L; D'Aprea L; D'Aprea L; D'Aprea L; Sepe V
    G Ital Chemioter; 1979; 26(1-2):41-56. PubMed ID: 122080
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of the "in vitro" activity of three aminoglycosides (gentamicin, tobramycin, and sisomicin) against "pseudomonas aeruginosa" strains (author's transl)].
    Berti P; Maranini B; Mazzoni P; Mori S
    Ann Sclavo; 1978; 20(5):696-706. PubMed ID: 111631
    [No Abstract]   [Full Text] [Related]  

  • 20. Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.
    Noone P
    Drugs; 1984 Jun; 27(6):548-78. PubMed ID: 6376062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.